Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
16 Aug 2024
Historique:
received: 06 02 2023
accepted: 22 07 2024
medline: 17 8 2024
pubmed: 17 8 2024
entrez: 16 8 2024
Statut: epublish

Résumé

Disruption of neocortical circuitry and architecture in humans causes numerous neurodevelopmental disorders. Neocortical cytoarchitecture is orchestrated by various transcription factors such as Satb2 that control target genes during strict time windows. In humans, mutations of SATB2 cause SATB2 Associated Syndrome (SAS), a multisymptomatic syndrome involving epilepsy, intellectual disability, speech delay, and craniofacial defects. Here we show that Satb2 controls neuronal migration and callosal axonal outgrowth during murine neocortical development by inducing the expression of the GPI-anchored protein, Semaphorin 7A (Sema7A). We find that Sema7A exerts this biological activity by heterodimerizing in cis with the transmembrane semaphorin, Sema4D. We could also observe that heterodimerization with Sema7A promotes targeting of Sema4D to the plasma membrane in vitro. Finally, we report an epilepsy-associated de novo mutation in Sema4D (Q497P) that inhibits normal glycosylation and plasma membrane localization of Sema4D-associated complexes. These results suggest that neuronal use of semaphorins during neocortical development is heteromeric, and a greater signaling complexity exists than was previously thought.

Identifiants

pubmed: 39152101
doi: 10.1038/s41467-024-51009-1
pii: 10.1038/s41467-024-51009-1
doi:

Substances chimiques

Semaphorins 0
Matrix Attachment Region Binding Proteins 0
Antigens, CD 0
Sema7a protein, mouse 0
Transcription Factors 0
SATB2 protein, mouse 0
Sema4d protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7059

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : 451346372

Informations de copyright

© 2024. The Author(s).

Références

Stouffer, M. A., Golden, J. A. & Francis, F. Neuronal migration disorders: focus on the cytoskeleton and epilepsy. Neurobiol. Dis. 92, 18–45 (2016).
Pan, Y.-H., Wu, N. & Yuan, X.-B. Toward a Better Understanding of neuronal migration deficits in autism spectrum disorders. Front. Cell Dev. Biol. 7 (2019).
Barnes, A. P. & Polleux, F. Establishment of axon-dendrite polarity in developing neurons. Annu. Rev. Neurosci. 32, 347–381 (2009).
Bradke, F. & Dotti, C. G. Establishment of neuronal polarity: lessons from cultured hippocampal neurons. Curr. Opin. Neurobiol. 10, 574–581 (2000).
pubmed: 11084319 doi: 10.1016/S0959-4388(00)00124-0
Epifanova, E. et al. Adhesion dynamics in the neocortex determine the start of migration and the post-migratory orientation of neurons. Sci. Adv. 7, eabf1973 (2021).
pubmed: 34215578 pmcid: 11060048 doi: 10.1126/sciadv.abf1973
Leone, D. P., Srinivasan, K., Chen, B., Alcamo, E. & McConnell, S. K. The determination of projection neuron identity in the developing cerebral cortex. Curr. Opin. Neurobiol. 18, 28–35 (2008).
pubmed: 18508260 pmcid: 2483251 doi: 10.1016/j.conb.2008.05.006
Leyva-Díaz, E. & López-Bendito, G. In and out from the cortex: development of major forebrain connections. Neuroscience 254, 26–44 (2013).
pubmed: 24042037 doi: 10.1016/j.neuroscience.2013.08.070
Moldrich, R. X. et al. Molecular regulation of the developing commissural plate. J. Comp. Neurol. 518, 3645–3661 (2010).
pubmed: 20653027 pmcid: 2910370 doi: 10.1002/cne.22445
Paolino, A., Fenlon, L. R., Suárez, R. & Richards, L. J. Transcriptional control of long-range cortical projections. Curr. Opin. Neurobiol. 53, 57–65 (2018).
pubmed: 29894898 doi: 10.1016/j.conb.2018.05.005
Alcamo, E. A. et al. Satb2 regulates callosal projection neuron identity in the developing cerebral cortex. Neuron 57, 364–377 (2008).
pubmed: 18255030 doi: 10.1016/j.neuron.2007.12.012
Britanova, O. et al. Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. Neuron 57, 378–392 (2008).
pubmed: 18255031 doi: 10.1016/j.neuron.2007.12.028
Döcker, D. et al. Further delineation of the SATB2 phenotype. Eur. J. Hum. Genet. 22, 1034–1039 (2014).
pubmed: 24301056 doi: 10.1038/ejhg.2013.280
Zarate, Y. A. & Fish, J. L. SATB2-associated syndrome: mechanisms, phenotype, and practical recommendations. Am. J. Med. Genet. A 173, 327–337 (2017).
pubmed: 27774744 doi: 10.1002/ajmg.a.38022
Zarate, Y. A. et al. Further supporting evidence for the SATB2-associated syndrome found through whole exome sequencing. Am. J. Med. Genet. 167, 1026–1032 (2015).
doi: 10.1002/ajmg.a.36849
Lewis, H. et al. Epilepsy and electroencephalographic abnormalities in SATB2-associated syndrome. Pediatr. Neurol. 112, 94–100 (2020).
pubmed: 32446642 doi: 10.1016/j.pediatrneurol.2020.04.006
Kolodkin, A. L. & Ginty, D. D. Steering clear of semaphorins: neuropilins sound the retreat. Neuron 19, 1159–1162 (1997).
pubmed: 9427240 doi: 10.1016/S0896-6273(00)80408-0
Nakamura, F., Kalb, R. G. & Strittmatter, S. M. Molecular basis of semaphorin-mediated axon guidance. J. Neurobiol. 44, 219–229 (2000).
pubmed: 10934324 doi: 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W
Tamagnone, L. & Comoglio, P. M. To move or not to move? EMBO Rep. 5, 356–361 (2004).
pubmed: 15060572 pmcid: 1299025 doi: 10.1038/sj.embor.7400114
Carulli, D., de Winter, F. & Verhaagen, J. Semaphorins in adult nervous system plasticity and disease. Front. Synaptic Neurosci. 13, 672891 (2021).
pubmed: 34045951 pmcid: 8148045 doi: 10.3389/fnsyn.2021.672891
Limoni, G. & Niquille, M. Semaphorins and Plexins in central nervous system patterning: the key to it all? Curr. Opin Neurobiol. 66, 224–232 (2021).
pubmed: 33513538 doi: 10.1016/j.conb.2020.12.014
Pasterkamp, R. J. & Giger, R. J. Semaphorin function in neural plasticity and disease. Curr. Opin. Neurobiol. 19, 263–274 (2009).
pubmed: 19541473 pmcid: 2730419 doi: 10.1016/j.conb.2009.06.001
Rizzolio, S. & Tamagnone, L. Semaphorin signals on the road to cancer invasion and metastasis. Cell Adhes. Migration 1, 62–68 (2007).
doi: 10.4161/cam.1.2.4570
Yazdani, U. & Terman, J. R. The semaphorins. Genome biology 7, 211 (2006).
pubmed: 16584533 pmcid: 1557745 doi: 10.1186/gb-2006-7-3-211
Jongbloets, B. C., Ramakers, G. M. J. & Pasterkamp, R. J. Semaphorin7A and its receptors: pleiotropic regulators of immune cell function, bone homeostasis, and neural development. Semin. Cell Dev. Biol. 24, 129–138 (2013).
pubmed: 23333497 doi: 10.1016/j.semcdb.2013.01.002
Jongbloets, B. C. et al. Stage-specific functions of Semaphorin7A during adult hippocampal neurogenesis rely on distinct receptors. Nat. Commun. 8, 14666 (2017).
pubmed: 28281529 pmcid: 5353663 doi: 10.1038/ncomms14666
Negishi, M., Oinuma, I. & Katoh, H. Plexins: axon guidance and signal transduction. Cell. Mol. Life Sci. 62, 1363–1371 (2005).
pubmed: 15818466 pmcid: 11139078 doi: 10.1007/s00018-005-5018-2
Tamagnone, L. et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99, 71–80 (1999).
pubmed: 10520995 doi: 10.1016/S0092-8674(00)80063-X
Perez-Branguli, F. et al. Reverse signaling by semaphorin-6a regulates cellular aggregation and neuronal morphology. PLoS ONE 11, e0158686 (2016).
pubmed: 27392094 pmcid: 4938514 doi: 10.1371/journal.pone.0158686
Andermatt, I. et al. Semaphorin 6B acts as a receptor in post-crossing commissural axon guidance. Development 141, 3709–3720 (2014).
Kang, S. et al. Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization. Nat. Immunol. 19, 561–570 (2018).
pubmed: 29777213 doi: 10.1038/s41590-018-0108-0
Sun, T. et al. A reverse signaling pathway downstream of Sema4A controls cell migration via Scrib. J. Cell Biol. 216, 199–215 (2017).
pubmed: 28007914 pmcid: 5223600 doi: 10.1083/jcb.201602002
Battistini, C. & Tamagnone, L. Transmembrane semaphorins, forward and reverse signaling: have a look both ways. Cell. Mol. Life Sci. 73, 1609–1622 (2016).
pubmed: 26794845 pmcid: 11108563 doi: 10.1007/s00018-016-2137-x
Srivatsa, S. et al. Unc5C and DCC act downstream of Ctip2 and Satb2 and contribute to corpus callosum formation. Nat. Commun. 5, 3708 (2014).
pubmed: 24739528 doi: 10.1038/ncomms4708
Chilton, J. K. Molecular mechanisms of axon guidance. Dev. Biol. 292, 13–24 (2006).
pubmed: 16476423 doi: 10.1016/j.ydbio.2005.12.048
Dudanova, I. & Klein, R. Integration of guidance cues: parallel signaling and crosstalk. Trends Neurosci. 36, 295–304 (2013).
pubmed: 23485451 doi: 10.1016/j.tins.2013.01.007
Kim, S. W. & Kim, K.-T. Expression of genes involved in axon guidance: how much have we learned? Int. J. Mol. Sci. 21, 3566 (2020).
pubmed: 32443632 pmcid: 7278939 doi: 10.3390/ijms21103566
Goebbels, S. et al. Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice. Genesis 44, 611–621 (2006).
pubmed: 17146780 doi: 10.1002/dvg.20256
McKenna, W. L. et al. Mutual regulation between Satb2 and Fezf2 promotes subcerebral projection neuron identity in the developing cerebral cortex. Proc. Natl Acad. Sci. 112, 11702–11707 (2015).
pubmed: 26324926 pmcid: 4577201 doi: 10.1073/pnas.1504144112
Hammal, F., de Langen, P., Bergon, A., Lopez, F. & Ballester, B. ReMap 2022: a database of human, mouse, Drosophila and Arabidopsis regulatory regions from an integrative analysis of DNA-binding sequencing experiments. Nucleic Acids Res. 50, D316–D325 (2022).
pubmed: 34751401 doi: 10.1093/nar/gkab996
Britanova, O. et al. A novel mode of tangential migration of cortical projection neurons. Dev. Biol. 298, 299–311 (2006).
pubmed: 16901480 doi: 10.1016/j.ydbio.2006.06.040
Jaitner, C. et al. Satb2 determines miRNA expression and long-term memory in the adult central nervous system. eLife 5, e17361 (2016).
pubmed: 27897969 pmcid: 5207769 doi: 10.7554/eLife.17361
Wahl, N. et al. SATB2 organizes the 3D genome architecture of cognition in cortical neurons. Mol. Cell 84, 621–639.e9 (2024).
pubmed: 38244545 doi: 10.1016/j.molcel.2023.12.024
Stiess, M. & Bradke, F. Neuronal polarization: the cytoskeleton leads the way. Dev. Neurobiol. 71, 430–444 (2011).
pubmed: 21557499 doi: 10.1002/dneu.20849
de Anda, F. C. et al. Centrosome localization determines neuronal polarity. Nature 436, 704–708 (2005).
pubmed: 16079847 doi: 10.1038/nature03811
Sakakibara, A. et al. Dynamics of centrosome translocation and microtubule organization in neocortical neurons during distinct modes of polarization. Cereb. Cortex 24, 1301–1310 (2014).
pubmed: 23307632 doi: 10.1093/cercor/bhs411
Yoshimura, T., Arimura, N. & Kaibuchi, K. Signaling networks in neuronal polarization. J. Neurosci. 26, 10626–10630 (2006).
pubmed: 17050700 pmcid: 6674748 doi: 10.1523/JNEUROSCI.3824-06.2006
Liu, H. et al. Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1. Cell 142, 749–761 (2010).
pubmed: 20727575 pmcid: 2936782 doi: 10.1016/j.cell.2010.07.040
Kong-Beltran, M., Stamos, J. & Wickramasinghe, D. The Sema domain of Met is necessary for receptor dimerization and activation. Cancer Cell 6, 75–84 (2004).
pubmed: 15261143 doi: 10.1016/j.ccr.2004.06.013
Marita, M. et al. Class A plexins are organized as preformed inactive dimers on the cell surface. Biophys. J. 109, 1937–1945 (2015).
pubmed: 26536270 pmcid: 4643210 doi: 10.1016/j.bpj.2015.04.043
Janssen, B. J. et al. Neuropilins lock secreted semaphorins onto plexins in a ternary signaling complex. Nat. Struct. Mol. Biol. 19, 1293–1299 (2012).
pubmed: 23104057 pmcid: 3590443 doi: 10.1038/nsmb.2416
Pasterkamp, R. J., Peschon, J. J., Spriggs, M. K. & Kolodkin, A. L. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 424, 398–405 (2003).
pubmed: 12879062 doi: 10.1038/nature01790
Kozlov, G. et al. Insights into function of PSI domains from structure of the Met receptor PSI domain. Biochem. Biophys. Res. Commun. 321, 234–240 (2004).
pubmed: 15358240 doi: 10.1016/j.bbrc.2004.06.132
Rozbesky, D. et al. Diversity of oligomerization in Drosophila semaphorins suggests a mechanism of functional fine-tuning. Nat. Commun. 10, 3691 (2019).
pubmed: 31417095 pmcid: 6695400 doi: 10.1038/s41467-019-11683-y
Sweeney, L. B. et al. Secreted semaphorins from degenerating larval orn axons direct adult projection neuron dendrite targeting. Neuron 72, 734–747 (2011).
pubmed: 22153371 pmcid: 3365565 doi: 10.1016/j.neuron.2011.09.026
Love, C. A. et al. The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D. Nat. Struct. Biol. 10, 843–848 (2003).
pubmed: 12958590 doi: 10.1038/nsb977
Elhabazi, A. et al. The human semaphorin-like leukocyte cell surface molecule CD100 associates with a serine kinase. Activity. J. Biol. Chem. 272, 23515–23520 (1997).
pubmed: 9295286 doi: 10.1074/jbc.272.38.23515
Janssen, B. J. C. et al. Structural basis of semaphorin-plexin signalling. Nature 467, 1118–1122 (2010).
pubmed: 20877282 pmcid: 3587840 doi: 10.1038/nature09468
Raissi, A. J., Staudenmaier, E. K., David, S., Hu, L. & Paradis, S. Sema4D localizes to synapses and regulates GABAergic synapse development as a membrane-bound molecule in the mammalian hippocampus. Mol. Cell Neurosci. 57, 23–32 (2013).
pubmed: 24036351 doi: 10.1016/j.mcn.2013.08.004
Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679–682 (2022).
pubmed: 35637307 pmcid: 9184281 doi: 10.1038/s41592-022-01488-1
Vaegter, C. B. et al. Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling. Nat. Neurosci. 14, 54–61 (2011).
pubmed: 21102451 doi: 10.1038/nn.2689
Pasterkamp, R. J. Getting neural circuits into shape with semaphorins. Nat. Rev. Neurosci. 13, 605–618 (2012).
pubmed: 22895477 doi: 10.1038/nrn3302
Gurrapu, S. et al. Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells. Sci. Signaling 12, eaav2041 (2019).
doi: 10.1126/scisignal.aav2041
Gherardi, E., Love, C. A., Esnouf, R. M. & Jones, E. Y. The sema domain. Curr. Opin. Struct. Biol. 14, 669–678 (2004).
pubmed: 15582390 doi: 10.1016/j.sbi.2004.10.010
Lu, D., Shang, G., He, X., Bai, X. & Zhang, X. Architecture of the Sema3A/PlexinA4/Neuropilin tripartite complex. Nat. Commun. 12, 3172 (2021).
pubmed: 34039996 pmcid: 8155012 doi: 10.1038/s41467-021-23541-x
Nogi, T. et al. Structural basis for semaphorin signalling through the plexin receptor. Nature 467, 1123–1127 (2010).
pubmed: 20881961 doi: 10.1038/nature09473
Delaire, S., Elhabazi, A., Bensussan, A. & Boumsell, L. CD100 is a leukocyte semaphorin. CMLS. Cell. Mol. Life Sci. 54, 1265–1276 (1998).
pubmed: 9849618 pmcid: 11147245 doi: 10.1007/s000180050252
Witherden, D. A. et al. The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function. Immunity 37, 314–325 (2012).
pubmed: 22902232 pmcid: 3430606 doi: 10.1016/j.immuni.2012.05.026
Nishide, M. et al. Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis. Ann. Rheumatic Dis. 76, 1440–1448 (2017).
doi: 10.1136/annrheumdis-2016-210706
Chataigner, L. M. P., Leloup, N. & Janssen, B. J. C. Structural perspectives on extracellular recognition and conformational changes of several type-I transmembrane receptors. Front. Mol. Biosci. 7, 129 (2020).
pubmed: 32850948 pmcid: 7427315 doi: 10.3389/fmolb.2020.00129
Kopp, M. A., Brommer, B., Gatzemeier, N., Schwab, J. M. & Prüss, H. Spinal cord injury induces differential expression of the profibrotic semaphorin 7A in the developing and mature glial scar. Glia 58, 1748–1756 (2010).
pubmed: 20645410 doi: 10.1002/glia.21045
Smith, E. S. et al. SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease. Neurobiol. Dis. 73, 254–268 (2015).
pubmed: 25461192 doi: 10.1016/j.nbd.2014.10.008
Clark, I. C. et al. Barcoded viral tracing of single-cell interactions in central nervous system inflammation. Science 372, eabf1230 (2021).
pubmed: 33888612 pmcid: 8157482 doi: 10.1126/science.abf1230
Evans, E. E. et al. Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity. J. Neuroinflammation 19, 200 (2022).
pubmed: 35933420 pmcid: 9356477 doi: 10.1186/s12974-022-02509-8
Zhu, L. et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc. Natl Acad. Sci. 104, 1621–1626 (2007).
pubmed: 17244710 pmcid: 1785259 doi: 10.1073/pnas.0606344104
Basile, J. R., Holmbeck, K., Bugge, T. H. & Gutkind, J. S. MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J. Biol. Chem. 282, 6899–6905 (2007).
pubmed: 17204469 doi: 10.1074/jbc.M609570200
Abad-Rodríguez, J. & Díez-Revuelta, N. Axon glycoprotein routing in nerve polarity, function, and repair. Trends Biochem. Sci. 40, 385–396 (2015).
pubmed: 25936977 doi: 10.1016/j.tibs.2015.03.015
McFarlane, I., Breen, K. C., Di Giamberardino, L. & Moya, K. L. Inhibition of N-glycan processing alters axonal transport of synaptic glycoproteins in vivo. Neuroreport 11, 1543–1547 (2000).
pubmed: 10841374 doi: 10.1097/00001756-200005150-00036
Pradeep, P., Kang, H. & Lee, B. Glycosylation and behavioral symptoms in neurological disorders. Transl. Psychiatry 13, 1–12 (2023).
doi: 10.1038/s41398-023-02446-x
Paprocka, J., Jezela-Stanek, A., Tylki-Szymańska, A. & Grunewald, S. Congenital disorders of glycosylation from a neurological perspective. Brain Sci. 11, 88 (2021).
pubmed: 33440761 pmcid: 7827962 doi: 10.3390/brainsci11010088
Shaikh, S. S. et al. A comprehensive functional analysis of NTRK1 missense mutations causing hereditary sensory and autonomic neuropathy type IV (HSAN IV). Hum. Mutation 38, 55–63 (2017).
doi: 10.1002/humu.23123
Watson, F. L., Porcionatto, M. A., Bhattacharyya, A., Stiles, C. D. & Segal, R. A. TrkA glycosylation regulates receptor localization and activity. J. Neurobiol. 39, 323–336 (1999).
pubmed: 10235685 doi: 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4
Kantor, D. B. et al. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 44, 961–975 (2004).
pubmed: 15603739 doi: 10.1016/j.neuron.2004.12.002
Pitkänen, A. & Sutula, T. P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 1, 173–181 (2002).
pubmed: 12849486 doi: 10.1016/S1474-4422(02)00073-X
Kuzirian, M. S., Moore, A. R., Staudenmaier, E. K., Friedel, R. H. & Paradis, S. The class 4 semaphorin Sema4D promotes the rapid assembly of GABAergic synapses in rodent hippocampus. J. Neurosci. 33, 8961–8973 (2013).
pubmed: 23699507 pmcid: 3713781 doi: 10.1523/JNEUROSCI.0989-13.2013
Acker, D. W. M., Wong, I., Kang, M. & Paradis, S. Semaphorin 4D promotes inhibitory synapse formation and suppresses seizures in vivo. Epilepsia 59, 1257–1268 (2018).
pubmed: 29799628 pmcid: 5990477 doi: 10.1111/epi.14429
Adel, S. S., Clarke, V. R. J., Evans-Strong, A., Maguire, J. & Paradis, S. Semaphorin 4D induced inhibitory synaptogenesis decreases epileptiform activity and alters progression to Status Epilepticus in mice. Epilepsy Res. 193, 107156 (2023).
pubmed: 37163910 pmcid: 10247425 doi: 10.1016/j.eplepsyres.2023.107156
Srivastava, A. et al. Transcriptomic profiling of high- and low-spiking regions reveals novel epileptogenic mechanisms in focal cortical dysplasia type II patients. Mol. Brain 14, 120 (2021).
pubmed: 34301297 pmcid: 8305866 doi: 10.1186/s13041-021-00832-4
Deng, J. et al. Sema7A, a brain immune regulator, regulates seizure activity in PTZ-kindled epileptic rats. CNS Neurosci. Therapeutics 26, 101–116 (2020).
doi: 10.1111/cns.13181
Fukunishi, A. et al. The action of Semaphorin7A on thalamocortical axon branching: Thalamocortical axon branching by Sema7A. J. Neurochem. 118, 1008–1015 (2011).
pubmed: 21781117 doi: 10.1111/j.1471-4159.2011.07390.x
Saito, T. In vivo electroporation in the embryonic mouse central nervous system. Nat. Protocols 1, 1552 (2006).
pubmed: 17406448 doi: 10.1038/nprot.2006.276
Polleux, F. & Ghosh, A. The slice overlay assay: a versatile tool to study the influence of extracellular signals on neuronal development. Science’s STKE 2002, pl9–pl9 (2002).
pubmed: 12060788
Franzoni, E. et al. miR-128 regulates neuronal migration, outgrowth and intrinsic excitability via the intellectual disability gene Phf6. eLife 4, e04263 (2015).
pubmed: 25556700 pmcid: 4337614 doi: 10.7554/eLife.04263
Bormuth, I. et al. Neuronal basic helix-loop-helix proteins Neurod2/6 regulate cortical commissure formation before midline interactions. J. Neurosci. 33, 641–651 (2013).
pubmed: 23303943 pmcid: 6704922 doi: 10.1523/JNEUROSCI.0899-12.2013
Burley, S. K. et al. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res. 49, D437–D451 (2021).
pubmed: 33211854 doi: 10.1093/nar/gkaa1038
Sumathi, K., Ananthalakshmi, P., Roshan, M. N. A. M. & Sekar, K. 3dSS: 3D structural superposition. Nucleic Acids Res. 34, W128–W132 (2006).
pubmed: 16844975 pmcid: 1538824 doi: 10.1093/nar/gkl036
Schrödinger, L. L. C. The PyMOL Molecular Graphics System Version 1.8 (Science and Education, 2015).
Hornbeck, P. V. et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512–D520 (2015).
pubmed: 25514926 doi: 10.1093/nar/gku1267

Auteurs

Paraskevi Bessa (P)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Andrew G Newman (AG)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Kuo Yan (K)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Theres Schaub (T)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Rike Dannenberg (R)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Denis Lajkó (D)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Julia Eilenberger (J)

Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.

Theresa Brunet (T)

Department of Pediatric Neurology and Developmental Medicine and Ludwig Maximilians University Center for Children with Medical Complexity, Dr. von Hauner Children's Hospital, Ludwig Maximilians University Hospital, Ludwig Maximilians University, Munich, Germany.
Institute of Human Genetics, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

Kathrin Textoris-Taube (K)

Institute of Biochemistry, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Philippstrasse 12, 10115, Berlin, Germany.
Core Facility - High-Throughput Mass Spectrometry, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Core Facility - High-Throughput Mass Spectrometry, Am Charitéplatz 1, Berlin, Germany.

Emanuel Kemmler (E)

Institute of Physiology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Philippstrasse 12, 10115, Berlin, Germany.

Penghui Deng (P)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Priyanka Banerjee (P)

Institute of Physiology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Philippstrasse 12, 10115, Berlin, Germany.

Ethiraj Ravindran (E)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Robert Preissner (R)

Institute of Physiology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Philippstrasse 12, 10115, Berlin, Germany.

Marta Rosário (M)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Victor Tarabykin (V)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany. victor.tarabykin@charite.de.
Institute of Neuroscience, Lobachevsky University of Nizhny Novgorod, Nizhny Novgorod, 603950, Russian Federation. victor.tarabykin@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH